A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AAV / adeno-associated virus

[Related PubMed/MEDLINE]
Total Number of Papers: 4581
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AAV  (>> Co-occurring Abbreviation)
Long Form:   adeno-associated virus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model. PD, PFF, SN, TH
2021 14-kDa phosphohistidine phosphatase is a potential therapeutic target for liver fibrosis. HSCs
2021 A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system. CSF, NHPs, rAAV, WT
2021 A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation. DMD, SaCas9, sgRNA, SpCas9
2021 A Crucial Role of ACBD3 Required for Coxsackievirus Infection in Animal Model Developed by AAV-Mediated CRISPR Genome Editing Technique. ACBD3, CVB3, sc
2021 A humanized mouse model of chronic COVID-19 to evaluate disease mechanisms and treatment options. COVID-19, SARS-CoV-2
2021 A quantitative PCR screening method for adeno-associated viral vector 2-mediated gene doping. qPCR, rAAV, wtAAV, WTAAV2
2021 A sensitive and reproducible cell-based assay via secNanoLuc to detect neutralizing antibody against adeno-associated virus vector capsid. MOI
2021 A simple adeno-associated virus-based approach for the generation of cardiac genetic models in rats. sh
10  2021 A Versatile In Vivo System to Study Myc in Cell Reprogramming. iPS
11  2021 AAV Delivery of shRNA Against TRPC6 in Mouse Hippocampus Impairs Cognitive Function. DG, GO, TRPC6
12  2021 AAV expressing an mTOR-inhibiting siRNA exhibits therapeutic potential in retinal vascular disorders by preserving endothelial integrity. HUVECs, mTOR, mTORC1, shRNA, VEGF
13  2021 AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy. PNS
14  2021 AAV-Containing Exosomes as a Novel Vector for Improved Gene Delivery to Lung Cancer Cells. AAVExo
15  2021 AAV-mediated AP-1 decoy oligonucleotide expression inhibits aortic elastolysis in a mouse model of marfan syndrome. dON, HP, MMPs
16  2021 AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challenge. FDA
17  2021 AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies. GSL, HSAN1A, HSPG26
18  2021 AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia. ACG, CAR
19  2021 AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo. CNS, SCI
20  2021 AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis. YAP
21  2021 AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear. ---
22  2021 AAV8 locoregional delivery induces long-term expression of an immunogenic transgene in macaques despite persisting local inflammation. AAV8, CMV, IM, LR
23  2021 AAV8-mediated Atoh1 overexpression induces dose-dependent regeneration of vestibular hair cells in adult mice. HCs
24  2021 AAV9 transduction mediated by systemic delivery of vector via retro-orbital injection in newborn, neonatal and juvenile mice. RO, ROI
25  2021 Absence of Significant Off-Target Splicing Variation with a U7snRNA Vector Targeting DMD Exon 2 Duplications. LSV, U7snRNA
26  2021 Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice. AD, FL-tau
27  2021 Accurate Quantification of AAV Vector Genomes by Quantitative PCR. qPCR
28  2021 Ad- and AAV8-mediated ABCA1 gene therapy in a murine model with retinal ischemia/reperfusion injuries. ABCA1, Ad, ANXA1, IR, RGC
29  2021 Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy - current and future perspectives. ---
30  2021 Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly. AAP, AAV-XV
31  2021 Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry. rAAV
32  2021 Adeno-associated virus (AAV)-based gene therapy for glioblastoma. GBM, i.c.v
33  2021 Adeno-associated Virus 9 Structural Rearrangements Induced by Endosomal Trafficking pH and Glycan Attachment. AAVs
34  2021 Adeno-associated virus gene therapy to the rescue for Charcot-Marie-Tooth disease type 4J. CMT4J
35  2021 Adeno-Associated Virus Vector for Central Nervous System Gene Therapy. CNS
36  2021 Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway In Vivo. CFI, iC3b
37  2021 Adeno-associated Virus Virus-like Particle Characterization via Orthogonal Methods: Nanoelectrospray Differential Mobility Analysis, Asymmetric Flow Field-Flow Fractionation, and Atomic Force Microscopy. AAV8, AFM, nES GEMMA, VLPs
38  2021 Adeno-associated virus-mediated delivery of anti-miR-199a tough decoys attenuates cardiac hypertrophy by targeting PGC-1alpha. miRNAs, TuDs
39  2021 Adeno-Associated Virus-Mediated Overexpression of Interleukin-10 Affects the Immunomodulatory Properties of Equine Bone Marrow-Derived Mesenchymal Stem Cells. BM-MSC, ECM, IL, OA, PTOA, TNF-alpha
40  2021 Advances in base editing with an emphasis on an AAV-based strategy. ABEs, CBEs, CRISPR
41  2021 Alcohol-induced Hsp90 acetylation is a novel driver of liver sinusoidal endothelial dysfunction and alcohol-related liver disease. ADH1, eNOS, HDAC6, Hsp90, LSEC, LSECs, NO
42  2021 Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue. ECs, EGFP, SMCs
43  2021 Alleviation of neurological disease by RNA editing. ---
44  2021 Amount of Green Fluorescent Protein in the Anterior Chamber after Intravitreal Injection of Triple-Mutated Self-Complementary AAV2 Vectors is Not Affected by Previous Vitrectomy Surgery. GFP, NAbs
45  2021 An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates. ---
46  2021 An ex vivo Approach to Assess Mitochondrial ROS by Flow Cytometry in AAV-tagged Astrocytes in Adult Mice. GFP, mROS
47  2021 Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions. ---
48  2021 Antioxidant activity of mesenchymal stem cell-derived extracellular vesicles restores hippocampal neurons following seizure damage. MSC-EVs, ROS
49  2021 Antisense Oligonucleotide Therapy for Ophthalmic Conditions. AON, IRD, mRNA
50  2021 Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice. ApoE, BBB, CNS, LDLR
51  2021 Application of ultrasound elastography for monitoring the effects of TβR1 shRNA therapy on hepatic fibrosis in a rat model. ARFI, PWV, shRNA, TGF
52  2021 Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challenges. BBB
53  2021 Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries. ANNs, ML, NGS, SVMs
54  2021 Assessment of quality attributes for adeno-associated viral vectors. QbD
55  2021 Astrocytic expression of the Alzheimer's disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical models. AD, NFTs
56  2021 Astrocytic mitochondria in adult mouse brain slices show spontaneous calcium influx events with unique properties. DLS, HPC, MTDR
57  2021 AUF1 gene transfer increases exercise performance and improves skeletal muscle deficit in adult mice. AUF1, PGC1alpha
58  2021 Augmentation of CD47/SIRPα signaling protects cones in genetic models of retinal degeneration. RP, SIRPalpha, TSP-1
59  2021 Axon regeneration after optic nerve injury in rats can be improved via PirB knockdown in the retina. CNS, CNTF, CTB, FVEP, GAP43, MAG, MAIs, NgR, OMgp, ONI, PirB, RGCs
60  2021 BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. BBB, CNS
61  2021 Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses. ---
62  2021 BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization. BMP9, CD, MCD, NASH, rhBMP9
63  2021 Bombyx mori Pupae Efficiently Produce Recombinant AAV2/HBoV1 Vectors with a Bombyx mori Nuclear Polyhedrosis Virus Expression System. BEV, BmNPV, HBoV1, rAAV, vg
64  2021 Boundary convection during sedimentation velocity in the Optima analytical ultracentrifuge. AUC, SV-AUC
65  2021 Brain-derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease. BDNF, MPTP, PD, TH
66  2021 C-C motif ligand 8 promotes atherosclerosis via NADPH oxidase 2/reactive oxygen species-induced endothelial permeability increase. CCL8, HAECs, NOX2, ROS
67  2021 c-Myc overexpression increases ribosome biogenesis and protein synthesis independent of mTORC1 activation in mouse skeletal muscle. HiMC, mTORC1
68  2021 C1q/TNF-related protein-9 ameliorates hypoxia-induced pulmonary hypertension by regulating secretion of endothelin-1 and nitric oxide mediated by AMPK in rats. CTRP9, ET, HPH, NO, p-eNOS, pAMPK, PMVECs
69  2021 CAPS1 is involved in hippocampal synaptic plasticity and hippocampus-associated learning. CAPS1, cKO, LTP
70  2021 Capsid Proteins Are Necessary for Replication of a Parvovirus. JcDV, NS, UTR
71  2021 Carbon Dot Nanoparticles: Exploring the Potential Use for Gene Delivery in Ophthalmic Diseases. CDs, IRD, NPs
72  2021 Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome. NAGLU
73  2021 Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia. CNS, MMA, MMUT
74  2021 CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's disease. AD, APP, CERTs
75  2021 Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. BBB, CNS
76  2021 Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes. ---
77  2021 Challenging Safety and Efficacy of Retinal Gene Therapies by Retinogenesis. RHO-adRP, TFs, TR
78  2021 Characterization of Adeno-Associated Virus Capsid Proteins with Two Types of VP3-Related Components by Capillary Gel Electrophoresis and Mass Spectrometry. CGE, LC-UV-MS, VPs
79  2021 Characterization of Gene Therapy Associated Uveitis Following Intravitreal Adeno-Associated Virus Injection in Mice. ---
80  2021 Characterization of Viral Genome Encapsidated in Adeno-associated Recombinant Vectors Produced in Yeast Saccharomyces cerevisiae. vg
81  2021 Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina. GFP, REP1
82  2021 Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors. ---
83  2021 Choline Acetyltransferase Induces the Functional Regeneration of the Salivary Gland in Aging SAMP1/Kl -/- Mice. ChAT
84  2021 CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner. RIP
85  2021 circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. circRNAs, FUS, GST, MAPK, MID1, OA, RIC8A, RPD
86  2021 CLEC-1 Acts as a Negative Regulator of Dectin-1 Induced Host Inflammatory Response Signature in Aspergillus fumigatus Keratitis. A. fumigatus, CFU, CLEC-1, MPO, PRRs, qRT-PCR
87  2021 Cloning of human ABCB11 gene in E. coli required the removal of an intragenic Pribnow-Schaller Box before it's Insertion into genomic safe harbor AAVS1 site using CRISPR-Cas9. PFIC2
88  2021 Comparative study of neuron-specific promoters in mouse brain transduced by intravenously administered AAV-PHP.eB. CaMKII, NSE, SynI-minCMV
89  2021 Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE. WPRE
90  2021 Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features. ---
91  2021 Comprehensive characterization and quantification of adeno associated vectors by size exclusion chromatography and multi angle light scattering. MALS, SEC
92  2021 Conditional RAC1 knockout in motor neurons restores H-reflex rate-dependent depression after spinal cord injury. SCI
93  2021 Context-Specific Function of the Engineered Peptide Domain of PHP.B. ---
94  2021 Control of Microbial Opsin Expression in Stem Cell Derived Cones for Improved Outcomes in Cell Therapy. hiPSC
95  2021 Correction: Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions. ---
96  2021 Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice. PD, PFF
97  2021 CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. cccDNA, HBV, Sa
98  2021 CRISPR-mediated rapid generation of neural cell-specific knockout mice facilitates research in neurophysiology and pathology. CNS, CRISPR, MS
99  2021 CRISPR/Cas9-Mediated in vivo Genetic Correction in a Mouse Model of Hemophilia A. APTT, FVIII, HA
100  2021 Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models. PK/PD